A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities (Q35891767)

11 August 2017

A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities (English)

1 reference

11 August 2017

1 reference

3

Georgia M Beasley

1 reference

11 August 2017

Christy Y Chai

1

1 reference

11 August 2017

Jeremiah L Deneve

2

1 reference

11 August 2017

Suroosh S Marzban

4

1 reference

11 August 2017

Y Ann Chen

5

1 reference

11 August 2017

Bhupendra Rawal

6

1 reference

11 August 2017

Stephen R Grobmyer

7

1 reference

11 August 2017

Steven N Hochwald

8

1 reference

11 August 2017

Douglas S Tyler

9

1 reference

11 August 2017

Jonathan S Zager

10

1 reference

11 August 2017

6 December 2011

1 reference

Annals of Surgical Oncology

11 August 2017

1 reference

11 August 2017

19

1 reference

11 August 2017

5

1 reference

11 August 2017

1637-1643

1 reference

New drugs in melanoma: it's a whole new world

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

Regional chemotherapy: overview

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

Current uses of isolated limb perfusion in the clinic and a model system for new strategies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

Frequency and duration of remission after isolated limb perfusion for melanoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

Regional therapy of melanoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

Maximizing efficacy and minimizing toxicity in isolated limb perfusion for melanoma.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515968

Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma

11 July 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2151-Z

Outcomes following isolated limb infusion for melanoma. A 14-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2151-Z

Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2151-Z

A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2151-Z

Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit

21 January 2018

1 reference

12 December 2020

Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan

1 reference

12 December 2020

Standardizing Regional Therapy: Developing a Consensus on Optimal Utilization of Regional Chemotherapy Treatments in Melanoma

1 reference

12 December 2020

Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma

1 reference

12 December 2020

Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics

1 reference

12 December 2020

The effect of regional perfusion treatment on recurrent melanoma of the extremities

1 reference

12 December 2020

Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions

1 reference

12 December 2020

Management of extremity recurrences after complete responses to isolated limb perfusion in patients with melanoma

1 reference

12 December 2020

A retrospective comparative study evaluating the results of a single-perfusion versus double-perfusion schedule with melphalan in patients with recurrent melanoma of the lower limb

1 reference

12 December 2020

Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)?

1 reference

12 December 2020

Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanoma

1 reference

12 December 2020

10.1245/S10434-011-2151-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

1013119107

0 references

Fatcat ID

release_75pvx327xfbkrdyzvtuwrgnn2a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/75pvx327xfbkrdyzvtuwrgnn2a

24 November 2022

mapped directly with Wikidata item

1 reference

11 August 2017

PubMed publication ID

22143576

1 reference